SG11201900005YA - Ghrelin secretion promotor - Google Patents

Ghrelin secretion promotor

Info

Publication number
SG11201900005YA
SG11201900005YA SG11201900005YA SG11201900005YA SG11201900005YA SG 11201900005Y A SG11201900005Y A SG 11201900005YA SG 11201900005Y A SG11201900005Y A SG 11201900005YA SG 11201900005Y A SG11201900005Y A SG 11201900005YA SG 11201900005Y A SG11201900005Y A SG 11201900005YA
Authority
SG
Singapore
Prior art keywords
ghrelin
ghrelin secretion
familiar
easy
safe
Prior art date
Application number
SG11201900005YA
Inventor
Akira Tamura
Satomi KOYAMA
Yukio Asami
Original Assignee
Meiji Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Co Ltd filed Critical Meiji Co Ltd
Publication of SG11201900005YA publication Critical patent/SG11201900005YA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/145—Gasseri
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Physiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

of the invention is to provide a novel, safe, and side effect-free ghrelin secretion promoter which is capable of exhibit secreting effect of ghrelin present in human body in a form of food that is familiar and easy to be taken in. Hypophagia (loss of appetite) can be remarkably improved by a familiar, easy and safe mean by taking a given lactic acid bacteria per se or fermented milk prepared using the same as a ghrelin secretion promoter.
SG11201900005YA 2016-07-14 2017-07-13 Ghrelin secretion promotor SG11201900005YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016139372A JP6813974B2 (en) 2016-07-14 2016-07-14 Ghrelin secretagogue
PCT/JP2017/025506 WO2018012578A1 (en) 2016-07-14 2017-07-13 Ghrelin secretion promotor

Publications (1)

Publication Number Publication Date
SG11201900005YA true SG11201900005YA (en) 2019-02-27

Family

ID=60953153

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201900005YA SG11201900005YA (en) 2016-07-14 2017-07-13 Ghrelin secretion promotor

Country Status (5)

Country Link
US (1) US20210290699A1 (en)
JP (1) JP6813974B2 (en)
CN (2) CN109715180B (en)
SG (1) SG11201900005YA (en)
WO (1) WO2018012578A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108094541A (en) * 2018-01-11 2018-06-01 黑龙江完达山林海液奶有限公司 A kind of flavored fermented milk for having the function of that health care is prebiotic and preparation method thereof
JP6515244B2 (en) * 2018-11-14 2019-05-15 株式会社明治 Ghrelin secretagogue

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2693584T3 (en) * 2006-01-27 2018-12-12 Dupont Nutrition Biosciences Aps Use of probiotic microorganisms for the treatment and prevention of obesity and related disorders
WO2009014421A1 (en) * 2007-07-25 2009-01-29 Campina Nederland Holding B.V. Probiotics for inducing satiety and/or satiation
DK2123168T3 (en) * 2008-05-16 2012-04-10 Nestec Sa Lactobacillus paracasei and weight control
JP5116731B2 (en) * 2009-06-29 2013-01-09 株式会社明治 Method for producing fermented milk
SG192109A1 (en) * 2011-01-25 2013-08-30 Meiji Co Ltd Gastrin production inhibitor and food composition comprising same
JP5967527B2 (en) * 2012-06-22 2016-08-10 国立研究開発法人産業技術総合研究所 Appetite increase and weight gain inhibitor
SG11201604840TA (en) * 2014-02-28 2016-09-29 Meiji Co Ltd Prophylactic and/or therapeutic agent for functional gastrointestinal disorders
JP2015205829A (en) * 2014-04-18 2015-11-19 雪印メグミルク株式会社 Hormone secretion promotor
AU2015258769A1 (en) * 2014-05-12 2016-12-01 Medlab Ip Pty Ltd Probiotic compositions and uses thereof for treatment of obesity-related disorders
TWI726846B (en) * 2014-06-25 2021-05-11 日商明治股份有限公司 Ghrelin secretion enhancer
JP5950993B2 (en) * 2014-12-25 2016-07-13 アサヒグループホールディングス株式会社 Vagus nerve activator

Also Published As

Publication number Publication date
JP2018008901A (en) 2018-01-18
JP6813974B2 (en) 2021-01-13
WO2018012578A1 (en) 2018-01-18
CN109715180A (en) 2019-05-03
US20210290699A1 (en) 2021-09-23
CN115918726A (en) 2023-04-07
CN109715180B (en) 2022-11-29

Similar Documents

Publication Publication Date Title
MX2022005890A (en) Methods for improving milk production by administration of microbial consortia.
MX2017004904A (en) Grafted plant body and method for producing same.
EP3473726B8 (en) Fermentation technique to improve production level of recombinant human collagen
PH12015500633A1 (en) Method for preparing imp fermented broth or glutamic acid fermented broth as raw material for preparation of natural flavor
MX2020003387A (en) Non-dairy fermented food product.
IN2012DN00282A (en)
PH12020550169A1 (en) Isothiocyanate containing brassicaceae products and method of preparation thereof
MY182593A (en) Composition containing chitin and digestible proteins
MX2017016283A (en) Lactobacillus paracasei for the production of conjugated linoleic acid, nutritional and pharmaceutical preparations containing it and uses thereof.
MX2016016871A (en) A method for improving the nutritional value of animal feed.
MY184520A (en) Method for preparing natural kokumi flavor
MX2018002307A (en) Lactobacillus fermentum bacteria reducing the concentration of acetaldehyde.
NZ733322A (en) Grape products for nonalcoholic fatty liver disease and other uses
EP3255140A4 (en) Lactic acid bacteria, natural immunoactivator and infection preventative/therapeutic derived from said lactic acid bacteria, and food/beverage
MX2016000661A (en) Process for preparing a fermented dairy product with reduced amount of lactose and improved nutritional and organoleptic properties.
PH12020550463A1 (en) Human milk fortifier composition
MX2016016995A (en) Composition containing phytic acid, magnesium and polyphenols for the treatment or prevention of renal lithiasis.
TW201613631A (en) Ghrelin secretion promoter
SG11201900005YA (en) Ghrelin secretion promotor
MX2013012045A (en) Peptides with antimicrobial activity, drug compositions for the prophylaxis and treatment of animals, compositions for the prophylaxis and treatment of plants, uses of said peptides, and uses of paenibacillus elgii ourofinensis extract.
MX2017001433A (en) Microscale bioprocessing system and method for protein manufacturing from human blood.
PH12015500683A1 (en) Formula fortifier
PH12019500710A1 (en) Methods and systems for generating a sterilized human milk product
PH12017550065A1 (en) Method for making a fermented food composition
MX2018000613A (en) Process for the preparation of a fermented milk product.